Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
KPRXCompany Name
KIORA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKIORA PHARMACEUTICALS INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPRX - EV/FCF Historical data
| Date | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 7.5M | 0 | $ -7.83M |
| 3/31/2025 | $ 6.28M | 0 | $ -7.72M |
| 12/31/2024 | $ 5.38M | 0.63 | $ 8.55M |
| 9/30/2024 | $ 5.01M | 0.61 | $ 8.23M |
| 6/30/2024 | $ 3.45M | 0.72 | $ 4.79M |
| 3/31/2024 | $ -18.42M | 0 | $ 7.14M |
| 12/31/2023 | $ 12.91M | 0 | $ -9.56M |
| 9/30/2023 | $ -399.76K | 0 | $ -9.1M |
| 6/30/2023 | $ -3.85M | 0 | $ -9.55M |
| 3/31/2023 | $ 1.76M | 0 | $ -10.67M |
Key Performance Insights, Last 5 Years
- KIORA PHARMACEUTICALS INC's latest trailing twelve months (TTM) EV/FCF stands at 0.
- Over the past 5 years, KIORA PHARMACEUTICALS INC's average EV/FCF has been 0.65.
- The median EV/FCF for KIORA PHARMACEUTICALS INC during this period was 0.63
- KIORA PHARMACEUTICALS INC reached its highest EV/FCF over the past 5 years at 0.72.
- The lowest EV/FCF recorded by KIORA PHARMACEUTICALS INC in the same timeframe 0.61
Similar metrics to FCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
Definition of Enterprise Value over Free Cash Flow
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].EV / FCF
(=) EV/FCF EV/FCF for KIORA PHARMACEUTICALS INC is calculated as follows: EV [ $ 12.63M ] / FCF [ $ -8.19M ]
(=) EV/FCF [ 0 ] KPRX - Enterprise Value over Free Cash Flow, Last 5 years
0.61
Minimum
Sep 30, 2024
0.72
Maximum
Jun 30, 2024
0.65
Average
0.63
Median
EV/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.48 with a standard deviation of 16.17.
The following table provides additional summary stats:
EV/FCF in the Market:
| filtered constituents | 2.2K |
|---|---|
| min | 0.05 |
| max | 78.21 |
| average | 23.48 |
| median | 19.11 |
| std | 16.17 |